Medications for Sarcopenia
No specific drugs are currently approved for the treatment of sarcopenia, but vitamin D supplementation should be strongly considered in patients with low baseline levels (<25 nmol/L or <30 ng/mL), particularly in older women, while other supplements like HMB and creatine may be considered in selected cases. 1
Primary Pharmacological Approach
The most recent 2026 EFIM guideline provides clear direction on pharmacotherapy for sarcopenia:
Vitamin D (STRONG recommendation)
- Should be considered for treatment, especially in older women with deficiency (<25 nmol/L or <30 ng/mL)
- This is the only supplement with a STRONG recommendation and moderate quality evidence 1
- Correct deficiency as part of baseline management
Conditional Supplements (WEAK recommendations)
β-hydroxy-β-methylbutyrate (HMB):
- Can be considered in selected patients to increase muscle mass
- Low quality evidence, but may help when combined with exercise 1
Creatine:
- Up to 3g daily can be considered alongside physical therapy
- Contraindicated in: heart failure, volume overload, or kidney disease (eGFR <30 mL/min/1.73 m²)
- May improve muscle mass and strength 1
Leucine:
- 3g/day may be considered in addition to vitamin D
- Works best when combined with exercise
- Efficacy depends on baseline nutritional status 1
Testosterone:
- May be considered only in older men with both clinical muscle weakness AND documented testosterone deficiency
- Requires careful risk-benefit assessment
- WEAK recommendation with low quality evidence 1
Medications NOT Recommended
The guideline provides a STRONG recommendation (moderate quality evidence) against the following agents 1:
- Growth hormone
- IGF-1
- DHEA
- ACE inhibitors (for sarcopenia specifically)
- Pioglitazone
- Beta-estradiol
- Norethisterone acetate
- SARMs (Selective Androgen Receptor Modulators)
- Bimagrumab
Critical Medication Considerations
Drugs That Worsen Sarcopenia (STRONG recommendations)
You must actively monitor and consider alternatives for:
GLP-1/GIP agonists:
- Consider worsening sarcopenia as a potential adverse effect
- Weight loss includes undesirable lean mass reduction 1
Corticosteroids:
- High doses and/or prolonged courses worsen sarcopenia
- Direct catabolic effects on muscle 1
Androgen deprivation therapy:
- For prostate cancer patients, especially >6 months duration
- Accelerates muscle atrophy 1
Practical Algorithm
- First-line: Check vitamin D levels → supplement if <25-30 ng/mL
- Second-line (selected patients): Consider HMB or creatine (if no contraindications) alongside exercise
- Specific populations: Leucine supplementation may augment protein intake in those with adequate baseline nutrition
- Men only: Consider testosterone if documented deficiency AND muscle weakness present
- Avoid: All other pharmacological agents listed above
Important Caveats
- Exercise and nutrition remain the cornerstone of treatment; medications are adjunctive only 1
- Protein intake of 1.2-1.5 g/kg/day is recommended (except in advanced CKD with eGFR <30) 1
- Most drugs that increase muscle mass do not translate to clinically meaningful improvements in physical performance 2, 3
- The evidence base is limited, with most recommendations based on low-quality studies 1
- No FDA-approved medications exist specifically for sarcopenia 1, 4, 2
The reality is that pharmacotherapy plays a minimal role in sarcopenia management. The focus should be on resistance training (2-3 sessions/week), adequate protein intake, and correcting vitamin D deficiency, while avoiding medications that accelerate muscle loss.